According to BeiGene
's latest financial reports the company has $3.53 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $3.53 B | -19.3% |
2022-12-31 | $4.38 B | -28.52% |
2021-12-31 | $6.13 B | 58.5% |
2020-12-31 | $3.86 B | 295.48% |
2019-12-31 | $0.97 B | -44.21% |
2018-12-31 | $1.75 B | 156.29% |
2017-12-31 | $0.68 B | 93.88% |
2016-12-31 | $0.35 B | 374.85% |
2015-12-31 | $74.31 M | 188.42% |
2014-12-31 | $25.76 M | -166.54% |
2013-12-31 | $-38.73 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $1.38 B | -60.73% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $14.51 M | -99.59% | ๐บ๐ธ USA |